TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in TherapeuticsMD, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- 0 vs. Q2 2024
- Shares held
- 3.38M
- +95.5K (+2.9%) vs. Q2 2024
- Total value
- $5.61M
- +$322.8K (+6.1%) vs. Q2 2024
- New holders
- 5
- 3 more added
- Sold out
- 5
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 44 | $8.10M |
| Q1 2026 | 49 | $7.94M |
| Q4 2025 | 44 | $5.52M |
| Q3 2025 | 46 | $3.54M |
| Q2 2025 | 42 | $3.78M |
| Q1 2025 | 42 | $3.09M |
| Q4 2024 | 41 | $3.03M |
| Q3 2024 | 37 | $5.61M |
| Q2 2024 | 38 | $5.49M |
| Q1 2024 | 43 | $7.73M |
| Q4 2023 | 39 | $7.32M |
| Q3 2023 | 36 | $9.02M |
| Q2 2023 | 42 | $12.5M |
| Q1 2023 | 41 | $11.7M |
| Q4 2022 | 44 | $19.4M |
| Q3 2022 | 43 | $13.8M |
| Q2 2022 | 53 | $20.3M |
| Q1 2022 | 125 | $40.4M |
| Q4 2021 | 132 | $44.1M |
| Q3 2021 | 150 | $98.2M |
| Q2 2021 | 155 | $203.9M |
| Q1 2021 | 162 | $237.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding TherapeuticsMD, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 1,192,191 | $1.98M | 0.03% | 00.0% | Unchanged |
| Clearline Capital LP | 636,622 | $1.06M | 0.09% | 00.0% | Unchanged |
| Tejara Capital Ltd | 401,446 | $666.4K | 0.32% | −491−0.1% | Reduced |
| Vanguard Group Inc | 387,582 | $643.4K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 270,160 | $448.5K | 0.08% | 00.0% | Unchanged |
| Morgan Stanley | 131,719 | $218.7K | 0.00% | +118+0.1% | Added |
| BlackRock, Inc. | 116,132 | $192.8K | 0.00% | +116,132 | New |
| Geode Capital Management, LLC | 108,333 | $179.9K | 0.00% | +12,856+13.5% | Added |
| Bridgeway Capital Management, LLC | 34,000 | $56.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 30,100 | $50.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 22,470 | $37.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,457 | $27.3K | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 13,562 | $22.5K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 8,289 | $13.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,847 | $8.05K | 0.00% | −4,269−46.8% | Reduced |
| Tower Research Capital LLC (TRC) | 2,270 | $3.77K | 0.00% | −1,264−35.8% | Reduced |
| National Bank of Canada | 610 | $1.01K | 0.00% | 00.0% | Unchanged |
| Capital Performance Advisors LLP | 600 | $996 | 0.00% | +600 | New |
| Bank of America Corp | 494 | $820 | 0.00% | +7+1.4% | Added |
| JPMorgan Chase & Co | 293 | $486 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 246 | $408 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 144 | $239 | 0.00% | −27−15.8% | Reduced |
| Principal Securities, Inc. | 126 | $209 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 120 | $199 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 80 | $133 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 56 | $92 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 40 | $66 | 0.00% | 00.0% | Unchanged |
| Provenance Wealth Advisors, LLC | 20 | $33 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 8 | $13 | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 4 | $7 | 0.00% | +4 | New |
| Guardian Wealth Management, Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 1 | $2 | 0.00% | +1 | New |
| Royal Bank of Canada | 154 | $0 | 0.00% | −80−34.2% | Reduced |
| TSFG, LLC | 64 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2 | $0 | 0.00% | +2 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,359−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,576−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |